Glossary term
Spravato
Esketamine nasal spray, the FDA-approved version of ketamine for treatment-resistant depression and major depression with acute suicidal ideation. Same mechanism as IV ketamine; different administration route.
Related Procedures
Spravato appears in the following procedure guides on ProcedureFinder: